Question

Difficulty: MediumBias, Confounding, and Validity

A retrospective cohort study evaluates the potential association between a newly marketed weight-loss medication and the incidence of new-onset atrial fibrillation. Investigators analyze the medical records of 20,000 adult patients over a 3-year follow-up period. The initial crude analysis reveals a relative risk (RR) of 2.1 (95%95\% CI: 1.6-2.8) for developing atrial fibrillation in patients prescribed the medication compared to those not taking it. The research team subsequently stratifies the data based on the patients' baseline history of obstructive sleep apnea (OSA). In the stratum of patients with a history of OSA, the RR is 1.1 (95%95\% CI: 0.8-1.5). In the stratum of patients without a history of OSA, the RR is 1.0 (95%95\% CI: 0.7-1.4). Which of the following is the most appropriate interpretation of the role of OSA in this study?

  1. It is a confounding variable that accounts for the initial crude association.Answer
  2. B
    It is an effect modifier that changes the magnitude of the medication's impact.
  3. C
    It introduces selection bias due to unequal loss to follow-up between the groups.
  4. D
    It is a causal mediator in the pathway between the medication and atrial fibrillation.
  5. E
    It indicates that an inappropriate inferential statistical test was utilized for the initial analysis.

Answer

It is a confounding variable that accounts for the initial crude association.
Confounding occurs when a third variable is associated with both the exposure (weight-loss medication) and the outcome (atrial fibrillation) but is not in the causal pathway. When data is stratified by a confounder, the apparent association seen in the crude analysis disappears or is significantly reduced in the individual strata. Because the relative risk dropped from 2.1 to approximately 1.0 in both OSA strata, OSA is a confounding variable that was driving the initial crude association.

Step-by-Step Solution

1
Analyze the results of the initial crude analysis.
The crude relative risk of 2.1 (95%95\% CI: 1.6-2.8) suggests a statistically significant increased risk of atrial fibrillation associated with the medication.
Establishing the baseline finding is necessary before evaluating how stratification affects the data.
2
Analyze the results after data stratification by the third variable (OSA).
In both strata (patients with OSA and patients without OSA), the relative risk drops to approximately 1.0 and the 95%95\% confidence intervals cross 1.0, rendering the results statistically non-significant.
Stratification is the standard epidemiological method used to differentiate between confounding and effect modification.
3
Determine the epidemiological role of the third variable based on the stratified results.
Because the significant association seen in the crude analysis completely disappears within the individual strata, the original association was falsely driven by the unequal distribution of OSA. Therefore, OSA is a confounder.
This matches the defining characteristic of confounding, distinguishing it from effect modification (where stratum-specific effects would significantly differ from one another).

Key Concept

Confounding versus Effect Modification
Rate this question